1.24
+0.03(+2.48%)
Currency In USD
| Previous Close | 1.21 |
| Open | 1.2 |
| Day High | 1.25 |
| Day Low | 1.19 |
| 52-Week High | 3.25 |
| 52-Week Low | 0.82 |
| Volume | 137,005 |
| Average Volume | 558,224 |
| Market Cap | 31.39M |
| PE | -1.46 |
| EPS | -0.85 |
| Moving Average 50 Days | 1.57 |
| Moving Average 200 Days | 1.62 |
| Change | 0.03 |
If you invested $1000 in Spectral AI, Inc. (MDAI) since IPO date, it would be worth $127.84 as of April 19, 2025 at a share price of $1.24. Whereas If you bought $1000 worth of Spectral AI, Inc. (MDAI) shares 3 years ago, it would be worth $126.53 as of April 19, 2025 at a share price of $1.24.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Spectral AI Raises up to $15 Million of Debt Financing and Strengthens Financial Position for U.S. Commercialization
GlobeNewswire Inc.
Mar 24, 2025 11:30 AM GMT
DALLAS, March 24, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ: MDAI) ("Spectral AI" or the "Company"), a leading developer of the AI-driven DeepView® System, which uses multi-spectral imaging and AI algorithms to predict burn healing potenti
Spectral AI Announces Public Filing of Registration Statement for Proposed Initial Public Offering of Spectral IP
GlobeNewswire Inc.
Mar 20, 2025 8:00 PM GMT
DALLAS, March 20, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. Food and Drug Administration in 2018 a
Spectral AI Announces Successful Results from its Burn Validation Study of the DeepView System
GlobeNewswire Inc.
Mar 17, 2025 11:00 AM GMT
DeepView® System outperforms burn physicians in identifying non-healing tissue Landmark Burn Validation Study, one of the largest in U.S. history, confirms DeepView’s performanceSpectral AI plans FDA submission by mid-2025, targeting De Novo Clearan
Data not available